A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor

MLA

Mira Woitok, et al. “A Novel Fully-Human Cytolytic Fusion Protein Based on Granzyme B Shows in Vitro Cytotoxicity and Ex Vivo Binding to Solid Tumors Overexpressing the Epidermal Growth Factor Receptor.” Cancer Letters, vol. 374, May 2016, pp. 229–40. EBSCOhost, https://doi.org/10.1016/j.canlet.2016.02.020.

APA

Mira Woitok, Christoph Stein, Rainer Fischer, Stefan Barth, Rolf Fendel, Judith Niesen, & Grit Hehmann-Titt. (2016). A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor. Cancer Letters, 374, 229–240. https://doi.org/10.1016/j.canlet.2016.02.020

Chicago

Mira Woitok, Christoph Stein, Rainer Fischer, Stefan Barth, Rolf Fendel, Judith Niesen, and Grit Hehmann-Titt. 2016. “A Novel Fully-Human Cytolytic Fusion Protein Based on Granzyme B Shows in Vitro Cytotoxicity and Ex Vivo Binding to Solid Tumors Overexpressing the Epidermal Growth Factor Receptor.” Cancer Letters 374 (May): 229–40. doi:10.1016/j.canlet.2016.02.020.